暗記メーカー
ログイン
biopharmaceutics
  • Hannah Angelique Losaria

  • 問題数 59 • 7/6/2024

    記憶度

    完璧

    8

    覚えた

    24

    うろ覚え

    0

    苦手

    0

    未解答

    0

    アカウント登録して、解答結果を保存しよう

    問題一覧

  • 1

    -most common but slowest -moves along the concentration gradient an therefore does not need ATP -does not need any carrier -based on fick's law of diffusion

    passive diffusion

  • 2

    the measure of rate and extent of drug entry into the sytemic circulation

    bioavailability

  • 3

    dominates when a substance is introduced to an environment with OPPOSITE ph

    ionized

  • 4

    proteins embedded in the matrix are used as receptors and for transport

    modified fuid mosaic

  • 5

    same API, different dose or dosage form

    pharmaceutical alternative

  • 6

    cardiac output regional blood flow

    physiological factors

  • 7

    ionized-water soluble

    dissolution

  • 8

    study of the pocess that a drug undergoes from the moment it enters the body unti it leaves - what the body doesto the drug

    pharmacokinetics

  • 9

    ionized

    charged

  • 10

    the study of pharmacotechnical factors in the drug products that ccan affect the pharmacokinetics of drugs -study of dosage forms and its dissolution properties

    biopharmaceutics

  • 11

    direction of active transport

    against the concentration gradient

  • 12

    THE ONLY BIOPHARMACEUTICS PROCESS -the process of converting the drug product to its solution form -a highly modifiable process and is considered as one of the primary determinants of the onset of action and duration of action

    liberation

  • 13

    rate and extent of drug entry into the sytemic circulation

    absorption

  • 14

    low partition coefficient

    water soluble

  • 15

    intrathecal

    cerebrospinal

  • 16

    area under the curve -measures extent

    auc

  • 17

    the process of removing or introducing a substance to a compartment

    transport

  • 18

    process of converting drugs to a less active form

    metabolism

  • 19

    the lipid bilayer has proteins embedded in the matrix

    fluid mosaic model

  • 20

    unionized

    uncharged

  • 21

    allows exchange of nutrients between the mother and the fetus

    placetal barrier

  • 22

    -follows immediate release graph but allows for a second release -fast onset

    bimodal release

  • 23

    compounnds containing water, making it easier to dissolve

    hydrates

  • 24

    time it takes to reach cmax -measures rate

    tmax

  • 25

    intraarticular

    joint space

  • 26

    -makes nonpolar drugs soluble in polar solvents

    slt formation

  • 27

    *a measure of how much the concentration changes from one compartment to another

    concentration gradient

  • 28

    drug ions bind to endogenous ions to form a neutral complex which is uncharged and is capable of passive diffusion

    ion pair transport

  • 29

    ratio of solubility in oil and water

    partition coefficient

  • 30

    -used to lower frequency of dosing -fast onset, long duration

    extnded release

  • 31

    -via water filled pores or channels -along the concentration gradient -solvent drag- ions move along the same direction as water -opposite charges -MW: 150-400 -transport system used by electrolytes

    convective transport

  • 32

    minimum toxic concentration is the highest concentration possible to cause an effect without any toxic effects

    maximum therapeutic concentration

  • 33

    -lag time is longer than that of the immediate release graph but allows for a second release graph -slow onset, short duration

    delayed release

  • 34

    unionized-lipid soluble

    absorption

  • 35

    dissolution is governed by what equation

    noyes-whitney

  • 36

    a space in the body pertaining to organs and tissues deemed as kinetically homogenous

    compartments

  • 37

    two layers of phospholipids wiith the hydrophilic heads faciing outside and the hydrophobic tails inside

    unit membrane theory/lipid bilayer

  • 38

    movement of drug from systemic circulation to different compartments

    distribution

  • 39

    intrasynovial

    joint fluid area

  • 40

    -high doseing frequency------ risk of noncompliace especially if polypharmacy -has the least lag time/liberation -fast onset, short duration

    immediate release

  • 41

    -stereo specific -competetive and saturable -follow michaeli menten kinetics

    carrier-mediated transport

  • 42

    amorphous form is more easily soluble than its crystallne form

    polymrphism

  • 43

    lowest possible concentration to cause an effect

    minimum effective concentration

  • 44

    classification of drugs based on dissolution and intestinal permeability, which affects absorption of the API

    biopharmaceutics classification system

  • 45

    -rate of diffusion is directly proportional to partition coefficient, surface area, concentration gradient -rate of diffusion is inversely proportional to the thickness of the membrane

    fick's law

  • 46

    for hormones

    globulin

  • 47

    recemic- equal portions of levo and dextro isomers

    chirality

  • 48

    direction of facilitated diffusion

    alonng the concentration gradient

  • 49

    same in all aspects but may differ in excipients

    pharmaceutical equivalent

  • 50

    different api, same drug class

    therapeutic alternative

  • 51

    -envagenation of cell membrane *phagocytosis *endocytosis *pinocytosis *exocytosis

    vesicular transport

  • 52

    who proposed the theory of cell membranes

    davson and danieli

  • 53

    high partition coefficient

    lipid soluble

  • 54

    creates a bigger compoud, making it less soluble

    complex formation

  • 55

    maximum plasma concentration -most variable parameter -measures rate and extent

    cmax

  • 56

    for acidic drugs

    albumin

  • 57

    the ratio of generic to innovator in terms of the pharmacokinetic parameters of biovailability

    bioequivalence

  • 58

    dominates when a substance isintrodced to an environment with the SAME ph

    unionized

  • 59

    same safety and efficacy- bioequivlent and phharmaceutical equivalent

    therapeutic equivalent